Cargando…
Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists
Chemotherapy is used to treat numerous cancers including melanoma. However, its effectiveness in clinical settings is often hampered by various mechanisms. Previous studies have demonstrated that prooxidative stressor-mediated generation of oxidized lipids with platelet-activating factor-receptor (P...
Autores principales: | Sahu, Ravi P., Ferracini, Matheus, Travers, Jeffrey B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398925/ https://www.ncbi.nlm.nih.gov/pubmed/25922565 http://dx.doi.org/10.1155/2015/820543 |
Ejemplares similares
-
Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands
por: Ferracini, Matheus, et al.
Publicado: (2014) -
New Insights Into the Pathologic Roles of the Platelet-Activating Factor System
por: Travers, Jeffrey B., et al.
Publicado: (2021) -
Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis
por: Hackler, Patrick C, et al.
Publicado: (2014) -
Exposure to diesel exhaust particulates and desert sand dust generates microvesicle particles and platelet‐activating factor agonists
por: Thyagarajan, Anita, et al.
Publicado: (2023) -
Radiation therapy generates platelet-activating factor agonists
por: Sahu, Ravi P., et al.
Publicado: (2016)